The Effect of Psychosocial Support on Improving Breast Cancer Patients Response to Medical Treatment

What this study involves

The registry does not currently label this study as recruiting. Ask about its status before planning a screening visit.

Study type

Interventional

Phase

Not applicable

Age range

20 years - 65 years

Sex eligible

Female

Healthy volunteers

Not accepted

Participants

160 Estimated

These are starting points, not an eligibility decision. The research team must review the full requirements.

About the research

The goal of this clinical trial is to evaluate the effect of psychosocial therapy on improving treatment response among breast cancer patients receiving chemotherapy. Participants will be randomized to receive standard medical treatment alone or combined with structured psychosocial therapy. Outcomes include treatment response, psychological well-being, and quality of life.

1. Do psychosocial interventions affect the response to breast cancer treatment?
2. How do societal attitudes toward psychological and social care influence the willingness of breast cancer patients in Palestine to seek psychosocial interventions?

Who may be able to participate?

The list below is the sponsor’s full registry wording. It can include conditions, prior treatment, test results and other requirements. A match in search does not mean you qualify.

Inclusion Criteria:

• age between 20-65 Being Palestinian female from west bank and Jerusalem
• Diagnosed with stage I-III breast cancer.
• Currently receiving active medical treatment.
• Able to provide consent and participate in the intervention.

Exclusion Criteria:

• being male.
• holding other nationalities than Palestinian or living outside the westbank or Jerusalem.
• Younger than 20 or older than 65 years old.
• Uncooperative with interviewer
• Terminally ill (stage IV).
• Receiving palliative care only.

Note Regarding the Modification of the Eligibility Criteria - Age Range

Please note that one of the study eligibility criteria has been revised, specifically the age range, which has been expanded from 20-65 years for several reasons.

First, the youth age group in Palestine is defined as individuals aged 18-65 years. Second, the disease affects patients across a broad range of ages rather than being limited to a specific age group. Finally, given the political and socioeconomic challenges facing our study, which may limit the availability and recruitment of patients across different age groups, particularly younger individuals, expanding the age range was considered necessary to facilitate patient recruitment and ensure a more representative study population.

Therefore, broadening the age eligibility criteria was deemed a practical and methodologically appropriate adjustment to address these challenges while improving the feasibility of the study.

Treatment, groups and participation

The registry may describe treatments and study duration without a complete visit calendar. Ask the study team for the exact schedule, procedures, risks, costs and alternatives. Keep your usual care plan unless your treating clinician tells you otherwise.

Assignment

Random assignment

Masking

No masking

What researchers are measuring

Outcome measures describe what is being studied. They are not proof that a treatment works.

Primary measures

Secondary measures

Research locations (1)

The overall study status and a local site’s status can differ. Confirm that location’s availability before traveling.

1 locations

Study team and timeline

Lead sponsor

Al-Quds University

Study start

Jul 30, 2027 Estimated

Primary completion

Jun 15, 2028 Estimated

Study completion

Dec 30, 2028 Estimated

First posted

Apr 14, 2026 Actual

Last updated

Nov 10, 2026 Actual

Official study contacts